Literature DB >> 23428317

A quasi-experimental study examining New York State's tobacco-free regulation: effects on clinical practice behaviors.

Lillian T Eby1, Tanja C Laschober.   

Abstract

BACKGROUND: On July 24, 2008, New York State (NYS) became the first state to require all state-funded or state-certified substance use disorder (SUD) treatment organizations to be 100% tobacco-free and offer tobacco cessation (TC) treatment.
METHODS: The current study used a quasi-experimental, non-equivalent control group design with a pretest and posttest to examine the effect of the NYS tobacco-free regulation on three clinical practice behaviors (use of TC-related intake procedures, use of guideline recommended counseling for TC, and pharmacotherapy availability) in a diverse sample of SUD treatment programs. Repeated cross-sectional data were collected from NYS counselors (experimental group) and non-NYS counselors (control group) approximately 4 months pre-regulation (N=282 and 659, respectively) and 10-12 months post-regulation (N=364 and 733, respectively).
RESULTS: Using mixed-effects models, results at pre-regulation indicate no group differences in the three clinical practice behaviors. However, significant post-regulation effects were found such that the experimental group reports greater use of TC-related intake procedures, guideline recommended counseling, and availability of pharmacotherapy than the control group. Additionally, the experimental but not the control group shows increases in all three clinical practice behaviors from pre-regulation to post-regulation.
CONCLUSIONS: We conclude that the NYS tobacco-free regulation had a significant and positive effect on promoting patient TC efforts among counselors.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Implementation; Longitudinal study; Substance abuse treatment workforce; Substance use disorder treatment; Tobacco cessation; Tobacco-free regulation

Mesh:

Year:  2013        PMID: 23428317      PMCID: PMC3676464          DOI: 10.1016/j.drugalcdep.2013.01.022

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  24 in total

1.  A longitudinal study of employee adaptation to organizational change: the role of change-related information and change-related self-efficacy.

Authors:  Nerina L Jimmieson; Deborah J Terry; Victor J Callan
Journal:  J Occup Health Psychol       Date:  2004-01

2.  A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery.

Authors:  Judith J Prochaska; Kevin Delucchi; Sharon M Hall
Journal:  J Consult Clin Psychol       Date:  2004-12

3.  The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey.

Authors:  Jill M Williams; Jonathan Foulds; Martha Dwyer; Bernice Order-Connors; Monifa Springer; Padma Gadde; Douglas M Ziedonis
Journal:  J Subst Abuse Treat       Date:  2005-06

4.  Differences in drug treatment services based on profit status.

Authors:  Isaac D Montoya
Journal:  J Psychoactive Drugs       Date:  2006-09

5.  Perceptions of organizational change: a stress and coping perspective.

Authors:  Alannah E Rafferty; Mark A Griffin
Journal:  J Appl Psychol       Date:  2006-09

6.  Sustainment of smoking cessation programs in substance use disorder treatment organizations.

Authors:  Hannah K Knudsen; Jessica Muilenburg; Lillian T Eby
Journal:  Nicotine Tob Res       Date:  2012-11-06       Impact factor: 4.244

Review 7.  Tobacco cessation with patients recovering from alcohol and other substance abuse.

Authors:  H E McIlvain; J K Bobo
Journal:  Prim Care       Date:  1999-09       Impact factor: 2.907

8.  Smoking cessation services in U.S. methadone maintenance facilities.

Authors:  Kimber P Richter; Won S Choi; Robert M McCool; Kari J Harris; Jasjit S Ahluwalia
Journal:  Psychiatr Serv       Date:  2004-11       Impact factor: 3.084

9.  A smoke-free chemical dependency unit. The Cleveland Clinic experience.

Authors:  M M Kotz
Journal:  J Subst Abuse Treat       Date:  1993 Mar-Apr

10.  Treating cigarette smoking in drug-abusing clients.

Authors:  B K Campbell; N Wander; M J Stark; T Holbert
Journal:  J Subst Abuse Treat       Date:  1995 Mar-Apr
View more
  6 in total

1.  Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016.

Authors:  Joseph Guydish; Deborah Yip; Thao Le; Noah R Gubner; Kevin Delucchi; Paul Roman
Journal:  Drug Alcohol Depend       Date:  2017-08-01       Impact factor: 4.492

2.  Prevalence of and Factors Related to Tobacco Ban Implementation in Substance Use Disorder Treatment Programs.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby; Nancy D Moore
Journal:  Adm Policy Ment Health       Date:  2016-03

3.  Barriers and Facilitators to Tobacco Cessation in a Nationwide Sample of Addiction Treatment Programs.

Authors:  Anna Pagano; Barbara Tajima; Joseph Guydish
Journal:  J Subst Abuse Treat       Date:  2016-05-05

4.  Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders.

Authors:  Shadi Nahvi; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2018-02-22       Impact factor: 4.492

5.  Factors Linked to Substance Use Disorder Counselors' (Non)Implementation Likelihood of Tobacco Cessation 5 A's, Counseling, and Pharmacotherapy.

Authors:  Tanja C Laschober; Jessica L Muilenburg; Lillian T Eby
Journal:  J Addict Behav Ther Rehabil       Date:  2015

6.  Organizational Factors Moderating Changes in Tobacco Use Dependence Care Delivery Following a Comprehensive Tobacco-Free Workplace Intervention in Non-Profit Substance Use Treatment Centers.

Authors:  Kathy Le; Tzuan A Chen; Isabel Martinez Leal; Virmarie Correa-Fernández; Ezemenari M Obasi; Bryce Kyburz; Teresa Williams; Kathleen Casey; Matthew Taing; Daniel P O'Connor; Lorraine R Reitzel
Journal:  Int J Environ Res Public Health       Date:  2021-10-06       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.